Safety and efficacy of tofacitinib up to 48 months in patients with active psoriatic arthritis: final analysis of the OPAL Balance long-term extension study
Titel:
Safety and efficacy of tofacitinib up to 48 months in patients with active psoriatic arthritis: final analysis of the OPAL Balance long-term extension study
Auteur:
Nash, Peter Coates, Laura C Fleishaker, Dona Kivitz, Alan J Mease, Philip J Gladman, Dafna D FitzGerald, Oliver Wang, Cunshan Wu, Joseph Hsu, Ming-Ann Menon, Sujatha Fallon, Lara Kanik, Keith S